Bio Diagnostics Company Investment Opportunity in Uxbridge, United Kingdom

• Healthcare business located in the United Kingdom offering gene therapy products and services.

• University spin-out with patented technology and other scientific developments in the pipeline.

• Aiming to improve the safety and efficiency of gene therapy.

• Top selling products will be tests to ascertain if a person can repair their DNA, testing if a virus used to deliver a gene therapy will actually be safe.

• Gene therapy and CAR-T therapy is a rapidly growing field, offering great potential for the company.

• Experienced team of scientists and engineers ready to create a successful business. The business is not operational currently.

• Unique products and services that can be marketed to potential customers worldwide.

Top selling products will be tests to ascertain if a person can repair their DNA, testing if a virus used to deliver a gene therapy will actually be safe.

None except the rights to have patents assigned to it once capital is raised.

Virtual at present but with rights to use university laboratories.

The current shareholders are two directors.

The company has no debt and a limited amount of cash received from grants.